Familial lipoprotein disorders in patients with premature coronary artery disease

Circulation

Volumn 85, Issue 6, 1992, Pages 2025-2033

  Genest Jr , Jacques J ^a   Martin Munley, Sarah S ^a   McNamara, Judith R ^a   Ordovas, Jose M ^a   Jenner, Jennifer ^a   Myers, Richard H ^c   Silberman, Steven R ^d   Wilson, Peter W F ^e   Salem, Deeb N ^b   Schaefer, Ernst J ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY   (United States)

^d Terumo Medical Corporation   (United States)

^e FRAMINGHAM HEART STUDY   (United States)

Author keywords

Coronary artery disease; Genetics; Lipids; Lipoproteine

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOTE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; HYPERTRIGLYCERIDEMIA; HYPOLIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

CORONARY DISEASE; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; HYPOLIPOPROTEINEMIA; LIPOPROTEIN(A); LIPOPROTEINS; MALE; MIDDLE AGE; PEDIGREE; PLASMINOGEN; PREVALENCE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026762806     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.85.6.2025     Document Type: Article

References (47)

1. Slack J, Evans KA: The increased risk of death from ischemic heart disease in first degree relatives of 121 men and 96 women with ischemic heart disease. J Med Genet 1966;3:329
2. Goldstein JL, Hazzard WR, Schrott WR, Bierman EL, Motulsky AG, Levinski MJ, Campbell ED: Hyperlipidemia in coronary heart disease: I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest 1973;52:1533-1543
3. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG, Campbell ED, Levinski MJ: Hyperlipidemia in coronary heart disease: II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973;52:1544-1568
4. Nikkila EA, Aro A: Family study of serum lipids and lipoproteine in coronary heart-disease. Lancet 1973;1:954-958
5. Rose HG, Kranz P, Weinstock M, Juliano J, Haft JI: Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype. Am J Med 1973;54:148-160
6. Vergani C, Bettale G: Familial hypo-alpha-lipoproteinemia. Clin Chim Acta 1981;114:45-52
7. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D: Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361,662 men. Lancet 1986;2:933-936
8. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB: Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Heart Study. JAMA 1986;256: 2835-2838
9. Papadapoulos NM, Bedynek JL: Serum lipoprotein patterns in patients with coronary atherosclerosis. Clin Chim Acta 1973;44:153-156
10. Frick MH, Dahlen G, Berg K, Valle M, Hekali P: Serum lipids in angiographically assessed coronary atherosclerosis. Chest 1978;73: 62-65
11. Sniderman AD, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO: Association of coronary atherosclerosis with hyperapobetalipoproteinemia. Proc Natl Acad Sci USA 1980;77:604-608
12. Maciejko JJ, Holmes DR, Kottke BA, Zinsmeister AR, Dinh DM, Mao SJT: Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med 1983;309:385-389
13. Durrington PN, Hunt L, Ishola M, Kane J, Stephens WP: Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction. Br Heart J 1986;56:206-212
14. Kottke BA, Zinsmeister AR, Holmes DR Jr, Kneller RW, Hallaway BJ, Mao SJT: Apolipoproteins and coronary artery disease. Mayo Clin Proc 1986;61:313-320
15. Dahlen GH, Guyton JR, Attar M, Fanner JA, Kautz JA, Gotto AM Jr: Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74:758-765
16. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986;59:199-204
17. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ: Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA 1989;86:587-591
18. Rall SC Jr, Weisgraber KH, Inneratity TL, Mahley RH: Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci U S A 1982;79:4696-4700
19. Karathanasis SK, Ferris E, Haddad IA: DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci U S A 1987;84:7198-7202
20. Ordovas JM, Cassidy DK, Civiera F, Bisgaier CL, Schaefer EJ: Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to a deletion of a gene complex on chromosome 11. J Biol Chem 1989;28:16349-16342
21. Russell DW, Esser V, Hobbs HH: Molecular basis of familial hypercholesterolemia. Arteriosclerosis 1989;9(suppl I):I-8-I-13
22. Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47
23. The Lipid Research Clinics: Population Studies Data Book: Vol I: The Prevalence Study. Washington, DC, US Department of Health and Human Services, NIH publication No. 80-1527, 1980
24. McNamara JR, Schaefer EJ: Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987;166:1-8
25. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 1982;28:1379-1387
26. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
27. Schaefer EJ, Ordovas JM: Metabolism of apolipoproteins A-I, A-II and A-IV. Meth Enzymol 1986;129:420-443
28. Ordovas JM, Peterson JP, Santaniello P, Cohn JS, Wilson PWF, Schaefer EJ: Enzyme-linked immonosorbent assay for human plasma apolipoprotein B. J Lipid Res 1987;28:1216-1224
29. Fredrickson DS, Levy RI, Lees RS: Fat transport in lipoproteins: An integrated approach to mechanisms and disorders. N Engl J Med 1967;276:34-44, 94-103, 215-225, 273-281
30. Third JLHC, Montag J, Flynn M, Freidel J, Laskarzewski P, Glueck CJ: Primary and familial hypoalphalipoproteinemia. Metabolism 1984;33:136-146
31. Borecki IB, Rao DC, Third JLHC, Laskarzewski PM, Glueck CJ: A major gene for primary hypoalphalipoproteinemia. Am J Hum Genet 1986;38:373-381
32. Brunzell JD, Sniderman AD, Albers JJ, Kwiterovich PO Jr: Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis 1984;4:79-83
33. Hopkins PN, Williams RR: Human genetics and coronary heart disease: A public health perspective. Annu Rev Nutr 1989;9:303-345
34. Schaefer EJ, Lery RI, Anderson DW, Danner RN, Brewer HB Jr, Blackwelder WC: Plasma triglycerides in the regulation of HDL. Lancet 1978;2:391-393
35. Chait A, Albers JJ, Brunzell JD: Very low density lipoprotein overproduction in genetic forms of hypertriglyceridemia. Eur J Clin Invest 1980;10:17-22
36. Sane T, Nikkila EA: Very low density lipoprotein triglyceride metabolism in relatives of hypertriglyceridemic probands: Evidence for genetic control of triglyceride removal. Arteriosclerosis 1988;8:217-226
37. Kissebah AH, Alfarsi S, Evans DJ: Low density lipoprotein metabolism in familial combined hyperlipidemia: Mechanisms of the multiple phenotype lipoprotein phenotypic expression. Atherosclerosis 1984;4:614-624
38. Schaefer EJ: Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency. Arteriosclerosis 1984;4:303-322
39. Grundy SM, Vega GL: Causes of high blood cholesterol. Circulation 1990;81:412-427
40. Utermann G: The mysteries of lipoprotein (a). Science 1989;246: 904-910
41. Lusis AJ: Genetic factors affecting blood lipoproteins: The candidate gene approach. J Lipid Res 1988;29:397-429
42. Genest J Jr, Ordovas JM, Robbins AM, Salem DN, Wilson PWF, Masherain U, Frossard PM, Meade T, Cohn S, Schaefer EJ: DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis 1990;82:7-17
43. Ordovas JM, Civeira F, Genest J Jr, Craig S, Robbins AM, Meade T, Pocovi M, Frossard PM, Masharani U, Wilson PWF, Salem DN, Ward RH, Schaefer EJ: Restriction fragment-length polymorphisms of the apolipoprotein AI-CIII-AIV gene locus, relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis 1991;87:75-86
44. Breslow JL: Genetic basis of lipoprotein disorders. J Clin Invest 1989;84:373-380
45. Genest J Jr, McNamara JR, Ordovas JM, Jenner JL, Silberman SR, Anderson KM, Wilson PWF, Salem DN, Schaefer EJ: Lipoprotein cholesterol, apolipoproteins A-I and B, and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 1992;19:792-802
46. Genest J Jr, McNamara JR, Upson B, Salem DN, Ordovas JM, Schaefer EJ, Malinow MR: Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease. Arterio Thromb 1991;11:1129-1136
47. Genest J Jr, Corbett HM, McNamara JR, Schaefer MM, Salem DN, Schaefer EJ: Effect of hospitalization on high-density lipoprotein cholesterol in patients undergoing elective coronary angiography. Am J Cardiol 1986;61:998-1000